USGovernment-News.Com

USGovernment-News.Com

News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
Press release distribution service
Home : U.S. Government News Search Engine                          

Home > U.S. Government News > Marketplace :
Home: United State Government News
Home | News | Submit Press Release |

Actos Lawsuits Claim Drug Causes Bladder Cancer

(EMAILWIRE.COM, March 02, 2012 ) New York, NY – Actos lawsuits filed against drug maker Takeda Pharmaceutical Co. claim that the diabetes drug causes bladder cancer. These Actos lawsuits further allege that the company knew about the bladder cancer risk and failed to provide adequate warnings to patients and the medical community. Because pharmaceutical companies have an obligation to provide proper warnings with their medications, patients who were diagnosed with bladder cancer after taking Actos may have legal recourse in light of these allegations. To find out if you can seek compensation for medical expenses and other damages through an Actos lawsuit, visit http://www.classaction.org/actos.html for a free case review.

According to reports, patients started contacting lawyers about the potential for Actos lawsuits shortly after the FDA released a safety announcement regarding Actos and bladder cancer. In June 2011, the agency announced that use of Actos (pioglitazone) for more than a year may be linked to an increased risk of bladder cancer.

Pioglitazone is sold as a single-ingredient product under the branded drug name Actos and is also sold in combination with metformin (Actoplus Met, Actoplus Met XR) and glimepiride (Duetact). According to the Actos bladder cancer announcement, results from a long-term, ongoing study revealed that patients with the longest exposure to pioglitazone and those exposed to the highest cumulative dose had an increased risk of developing bladder cancer.

The FDA announced that due to the potential Actos bladder cancer risk, the drug should not be prescribed in patients with active bladder cancer and used with caution in those with a history of the illness. If you or a loved one has contracted bladder cancer after taking diabetes drug Actos, Actoplus Met, Actoplus Met XR or Duetact, you may be able to file an Actos lawsuit to seek compensation for medical bills, pain and suffering and other damages. For more information on Actos lawsuits and to receive a free evaluation of your bladder cancer claim, visit Class Action.org. The Actos lawsuit attorneys working with the site are providing this online consultation with no cost and no obligation.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org
Hannah Armstrong
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com

U.S. Governement News: Politics
  • Presidential Elections
  • Democrates
  • Congress
  • House of Representatives
  • President Obama
  • Republican Party
  • Mitt Romney
  • U.S. Senate
  • U.S. Military
  • U.S. Politics
  • Politics Video Feeds

    U.S. Government Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    USGovernment-News.Com is a news service of GroupWeb Media LLC